Drugs for Duodenal Ulcer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 65)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Dexlansoprazole |
Approved, Investigational |
Phase 4 |
|
138530-94-6 |
9578005 |
Synonyms:
(+)-LANSOPRAZOL
(R)-LANSOPRAZOLE
2-((R)-((3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)-2-PYRIDINYL)METHYL)SULFINYL)-1H-BENZIMIDAZOLE
DEXILANT
DEXILANT SOLUTAB
DEXLANSOPRAZOLE
KAPIDEX
|
LANSOPRAZOLE R-FORM
R-lansoprazole
T 168390
T-168390
TAK 390
TAK-390
|
|
2 |
|
Lansoprazole |
Approved, Investigational |
Phase 4 |
|
103577-45-3 |
3883 |
Synonyms:
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole
A-65006
Abbot brand OF lansoprazole
AG 1749
AG-1749
Agopton
Almirall brand OF lansoprazole
Amarin
Aprazol
Bamalite
Biuret
Biuret Gr
Biuret Reagent
Biuret Reagent Solution
Blason
Compraz
Dakar
Hoechst brand OF lansoprazole
Hormona brand OF lansoprazole
Ilsatec
Ketian
Lancid
Lanfast
Lanproton
Lansol
Lansopep
Lansophed
Lansoprazol
Lansoprazol [INN-Spanish]
LANSOPRAZOLE
Lansoprazole [Usan:Ban:Inn]
Lansoprazole abbot brand
Lansoprazole almirall brand
Lansoprazole hoechst brand
Lansoprazole hormona brand
Lansoprazole lederle brand
Lansoprazole promeco brand
Lansoprazole salvar brand
Lansoprazole sodium
Lansoprazole takeda brand
Lansoprazole tap brand
Lansoprazole tecnobio brand
Lansoprazole vinas brand
Lansoprazole wyeth brand
Lansoprazoles
Lansoprazolum
|
Lansoprazolum [INN-Latin]
Lansox
Lanston
Lanz
Lanzo
Lanzol
Lanzol-30
Lanzopral
Lanzor
Lanzul
Lapraz
Lasoprol
Lederle brand OF lansoprazole
Limpidex
Linamarin
Mesactol
Monolitum
Ogast
Ogastro
Opiren
Prevacid
PREVACID (TN)
PREVACID 24HR
PREVACID DELAYED RELEASE
PREVACID IV
PREVACID SOLUTAB
Prevpac
Prezal
Pro ulco
Promeco
promeco Brand OF lansoprazole
Promp
Prosogan
Salvar brand OF lansoprazole
Sodium, lansoprazole
Suprecid
Takeda brand OF lansoprazole
Takepron
TAP brand OF lansoprazole
tecnobio Brand OF lansoprazole
Ulpax
Vinas brand OF lansoprazole
Wyeth brand OF lansoprazole
Zoprol
Zoton
|
|
3 |
|
Amoxicillin |
Approved, Vet_approved |
Phase 4 |
|
26787-78-0 |
33613 |
Synonyms:
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(p-Hydroxy-a-aminophenylacetamido)penicillanate
6-(p-Hydroxy-a-aminophenylacetamido)penicillanic acid
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanate
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-Hydroxy-α-aminophenylacetamido)penicillanate
6-(p-Hydroxy-α-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9ci
a-Amino-p-hydroxybenzylpenicillin
Actimoxi
Almodan
alpha-Amino-p-hydroxybenzylpenicillin
AMC
Amix
AMIX 125
AMIX 250
AMIX 500
Amoclen
Amolin
Amopen
Amopenixin
Amoram
AMOX
Amox 250 cap 250MG
Amox 500 cap 500MG
Amox S 125 sus 125mg/5ML
Amox S 250 sus 250mg/5ML
Amoxi
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
Amoxicillin
Amoxicillin (anhydrous)
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin clariana brand
AMOXICILLIN HYDRATE
Amoxicillin monopotassium salt
Amoxicillin monosodium salt
Amoxicillin pediatric
Amoxicillin sodium
Amoxicillin trihydrate
Amoxicillin(usan)
Amoxicillin, (r*)-isomer
Amoxicilline
Amoxicilline [INN-French]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
AMOXIDENT 250
AMOXIDENT 500
AMOXI-INJECT
Amoxil
AMOXIL FIZTAB
AMOXIL SF
Amoxi-mast
AMOXI-TABS
Amoxivet
Amoxycilin
Amoxycillin
AMOXYCILLIN ANHYDROUS
Amoxycillin trihydrate
Amoxycillin, ban
Amoxymed
AMPC
Amrit
Anemolin
Anhydrous, amoxicillin
Apo-amoxi
Apo-amoxi cap 250MG
Apo-amoxi cap 500MG
Apo-amoxi PWR for susp 125mg/5ML
Apo-amoxi PWR for susp 250mg/5ML
Apo-amoxi sugar free
AQUACIL
Aspenil
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
|
AUGMENTIN '875'
AUGMENTIN es-600
AX
Biomox
Bristamox
BRL 2333
BRL-2333
Cemoxin
Clamoxyl
Clamoxyl (SKB)
Clamoxyl g.a.
Clamoxyl parenteral
Clariana brand OF amoxicillin
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
DEDOXIL
Delacillin
Dispermox
Efpenix
Flemoxin
FLEMOXIN SOLUTAB
G.A., clamoxyl
Galenamox
Gen-amoxicillin 250MG
Gen-amoxicillin 500MG
Hiconcil
Histocillin
Hydroxyampicillin
Ibiamox
Imacillin
Lamoxy
Larotid
Metafarma capsules
Metifarma capsules
Moxacin
Moxal
Moxatag
Novamoxin cap 250MG
Novamoxin cap 500MG
Novamoxin sus 125mg/5ML
Novamoxin sus 250mg/5ML
NSC-277174
Nu-amoxi cap 250MG
Nu-amoxi cap 500MG
Nu-amoxi sus 125/5ML
Nu-amoxi sus 250mg/5ML
Ospamox
Pamoxicillin
Parenteral, clamoxyl
Penamox
Pfizer brand OF amoxicillin sodium salt
PHL-Amoxicillin
p-Hydroxyampicillin
Piramox
PMS-Amoxicillin
Polymox
Prevpac
Pro amox PWR for oral susp 125mg/5ML
Pro amox-250 cap 250MG
Pro amox-500 cap 500MG
Pro-amox-250 orl sus 250mg/5ML
RESPILLIN
R-Hydroxyampicillin
Rimoxallin
Robamox
Sauracillin
Sawamox PM
SmithKline beecham brand OF amoxicillin sodium salt
Sodium, amoxicillin
Sumox
Tolodina
Trihydrate, amoxicillin
Trimox
Unicillin
Utimox
Vetramox
VETREMOX
Wymox
Zimox
ZOXYCIL 250
ZOXYCIL 500
Α-amino-p-hydroxybenzylpenicillin
|
|
4 |
|
Potassium citrate |
Approved, Investigational, Vet_approved |
Phase 4 |
|
866-84-2 |
|
Synonyms:
Potassium citrate anhydrous
Potassium citric acid
|
Tripotassium 2-hydroxypropane-1,2,3-tricarboxylate
Tripotassium citrate
|
|
5 |
|
Sodium citrate |
Approved, Investigational |
Phase 4 |
|
68-04-2 |
23431961 |
Synonyms:
Anhydrous sodium citrate
Anhydrous trisodium citrate
Citric acid, trisodium salt
Natrii citras
Natrocitral
Sodium citrate anhydrous
Sodium citrate, anhydrous
|
Sodium citrate,anhydrous
Sodium citric acid
Trisodium 2-hydroxypropane-1,2,3-tricarboxylate
trisodium citrate anhydrous
Trisodium citrate, anhydrous
Trisodium-citrate
|
|
6 |
|
Esomeprazole |
Approved, Investigational, Vet_approved |
Phase 4 |
|
73590-58-6, 119141-88-7 |
9568614 4594 |
Synonyms:
( -)-Omeprazole
(−)-omeprazole
(-)-Omeprazole
(S)-(−)-omeprazole
(S)-(-)-Omeprazole
(S)-5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
(S)-5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole
(S)-Omeprazole
(S)-omeprazole|Nexium®
2,3,5-Trimethylpyridine/Omeprazole
A02BC05
Alenia
Antra
Antra mups
AstraZeneca brand OF esomeprazole magnesium
Audazol
Aulcer
Axagon
Belmazol
Ceprandal
Danlox
Demeprazol
Desec
Dizprazol
Dudencer
Elgam
Emeproton
EMOZUL
Epirazole
Erbolin
Escz
Esofag
Esomeprazol
Esomeprazole
Ésoméprazole
Esomeprazole magnesium
Esomeprazole potassium
Esomeprazole sodium
Esomeprazole strontium
Esomeprazole strontium anhydrous
Esomeprazolum
Esomperazole
Esopral
Exter
Gasec
Gastrimut
Gastroloc
Gibancer
H 168/68
H 168/68|Losec®|Prilosec®
H-168/68
Indurgan
Inexium paranova
Inhibitron
Inhipump
Lensor
Logastric
Lomac
Losec
LOSEC MUPS
Lucen
Magnesium, omeprazole
Mepral
MEZZOPRAM
Miol
Miracid
Mopral
Morecon
Nexiam
Nexium
NEXIUM CONTROL
NEXIUM I.V.
Nexium IV
Nilsec
Nopramin
|
Nuclosina
Ocid
Olexin
Omapren
Omebeta 20
Omed
Omegast
OMEP
Omepradex
Omepral
Omeprazol
Omeprazol [INN-Spanish]
Omeprazole
Omeprazole magnesium
Omeprazole pellets
Omeprazole S-form
Omeprazole sodium
Omeprazolum
Omeprazolum [INN-Latin]
Omeprazon
Omeprol
OMERAN
Omesek
Omez
Omezol
Omezolan
Omid
Omisec
Omizac
OMP
Ompanyt
OMZ
Ortanol
Osiren
Ozoken
Paprazol
Parizac
Pepticum
Pepticus
Peptilcer
Perprazole
Prazentol
Prazidec
Prazolit
Prestwick_808
Prilosec
Prilosec otc
Procelac
Proclor
Prysma
Ramezol
Regulacid
Result
Sanamidol
Secrepina
Sodium, omeprazole
Strontium, esomeprazole
Tedec ulceral
Ulceral
Ulcesep
Ulcometion
Ulcozol
Ulcsep
Ulsen
Ultop
Ulzol
VENTRA
Victrix
ZANPROL
Zefxon
Zegerid
Zepral
Zimor
Zoltum
|
|
7 |
|
Doxycycline |
Approved, Investigational, Vet_approved |
Phase 4 |
|
564-25-0 |
54671203 |
Synonyms:
(4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
5-Hydroxy-a-6-deoxytetracycline
5-Hydroxy-alpha-6-deoxytetracycline
5-Hydroxy-α-6-deoxytetracycline
6a-Deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
6alpha-Deoxy-5-oxytetracycline
6Α-deoxy-5-oxytetracycline
Anhydrous doxycycline
BMY-28689|Monodox®|Vibramycin®
Doxcycline anhydrous
Doxiciclina
DOXY
Doxychel
Doxycyclin
Doxycycline
|
Doxycycline (anhydrous)
DOXYCYCLINE ANHYDROUS
DOXYCYCLINE HCL
Doxycycline hyclate
Doxycycline hydrate
Doxycycline hydric acid
Doxycycline monohydrate
Doxycycline monohydric acid
Doxycyclinum
Doxytetracycline
GS-3065
Jenacyclin
Monodox
Oracea
Supracyclin
Vibramycin
|
|
8 |
|
Ranitidine |
Approved, Withdrawn |
Phase 4 |
|
66357-59-3, 82530-72-1, 66357-35-5 |
3001055 5039 |
Synonyms:
(e)-Ranitidine
1-N'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulphanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine
2-(Benzhydryloxy)-N,N-dimethylethylamine
2-Diphenylmethoxy-N,N-demthylethanamine
2-Diphenylmethoxy-N,N-dimethylethylamine
a-(2-Dimethylaminoethoxy)diphenylmethane
Achedos
Acidex
AH-19065|Gavilast®|GR-122311X|Zantac®
Alledryl
Allerdryl
Allergan
Allergina
alpha-(2-Dimethylaminoethoxy)diphenylmethane
Atural
Axoban
b-Dimethylaminoethanol diphenylmethyl ether
b-Dimethylaminoethyl benzhydryl ether
Benadryl
Bendylate
Benhydramin
Benylin
Benzantin
Benzhydramine
beta-Dimethylaminoethanol diphenylmethyl ether
beta-Dimethylaminoethyl benzhydryl ether
Biotidin
Citrate, diphenhydramine
Coralen
Curan
Difenhidramina
Difenhydramine
Dimedrol
Dimedrolum
Dimethyl[(5-{[(2-{[1-(methylamino)-2-nitroethenyl]amino}ethyl)sulphanyl]methyl}furan-2-yl)methyl]amine
Dimethylamine benzhydryl ester
Diphamine
Diphantine
Diphenhydramine citrate
Diphenhydramine citrate (1:1)
Diphenhydramine hydrochloride
Diphenhydraminum
Diphenylhydramin
Diphenylhydramine
Dobacen
Dormin
Duractin
Ezopta
Gastrial
Gastrosedol
Hydrochloride, diphenhydramine
Hydrochloride, ranitidine
Istomar
|
Logast
Mauran
Microtid
N (2-(((5-((dimethylamino)Methyl)-2-furanyl)methyl)thio)ethyl)-n'-methyl-2-nitro-1,1-ethenediamine
N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine
O-Benzhydryldimethylaminoethanol
Ptinolin
Quantor
Quicran
Radinat
RAN
Randin
Ranidine
Ranin
Raniogas
Ranisen
Raniter
Ranitidin
Ranitidina
Ranitidine
Ranitidine (form I and form II)
Ranitidine base
Ranitidine HCL 1/2 type
Ranitidine hydrochloride
Ranitidinum
Ranitiget
Rantacid
Rantidine
Ratic
Raticina
Restamin
RND
Sampep
Sostril
Taural
Tritec
Ulceranin
Ul-pep
Urantac
Verlost
Vesyca
Vizerul
Weichilin
Weidos
Xanidine
Zantab
Zantac
Zantadin
Zantic
Α-(2-dimethylaminoethoxy)diphenylmethane
Î’-dimethylaminoethanol diphenylmethyl ether
Î’-dimethylaminoethyl benzhydryl ether
|
|
9 |
|
Sucralfate |
Approved |
Phase 4 |
|
54182-58-0 |
|
Synonyms:
ANTEPSIN
CARAFATE
Hexadeca-μ-hydroxytetracosahydroxy[μ8-[1,3,4,6-tetra-O-sulfo-β-Dfructofuranosyl-α-D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum
Octaaluminium(3+) ion (2R,3S,4S,5R)-2,4-bis(sulfonatooxy)-5-[(sulfonatooxy)methyl]-5-{[(2S,3R,4S,5R,6R)-3,4,5-tris(sulfonatooxy)-6-[(sulfonatooxy)methyl]oxan-2-yl]oxy}oxolan-3-yl sulfuric acid hexadecahydroxide
Octaaluminium(3+) ion (2R,3S,4S,5R)-2,4-bis(sulphonatooxy)-5-[(sulphonatooxy)methyl]-5-{[(2S,3R,4S,5R,6R)-3,4,5-tris(sulphonatooxy)-6-[(sulphonatooxy)methyl]oxan-2-yl]oxy}oxolan-3-yl sulphate hexadecahydroxide
Octaaluminium(3+) ion (2R,3S,4S,5R)-2,4-bis(sulphonatooxy)-5-[(sulphonatooxy)methyl]-5-{[(2S,3R,4S,5R,6R)-3,4,5-tris(sulphonatooxy)-6-[(sulphonatooxy)methyl]oxan-2-yl]oxy}oxolan-3-yl sulphuric acid hexadecahydroxide
Sucralfat
|
Sucralfate
SUCRALFATE HYDRATE
Sucralfato
Sucralfatum
Sucralfic acid
ULCERLMIN
|
|
10 |
|
Pantoprazole |
Approved |
Phase 4 |
|
102625-70-7, 138786-67-1 |
4679 |
Synonyms:
6-(DIFLUOROMETHOXY)-2-{[(3,4-DIMETHOXYPYRIDIN-2-YL)METHANE]SULFINYL}-1H-1,3-BENZODIAZOLE
Astropan
BY-1023
PAN023
Pantoloc
PANTOLOC CONTROL
Pantopan
Pantoprazol
Pantoprazol [INN-Spanish]
PANTOPRAZOLE
Pantoprazole Na
Pantoprazole sodium
Pantoprazole sodium hydrate
Pantoprazolum
Pantoprazolum [INN-Latin]
|
Pantoprozole
Pantor
Pantozol
PROTIUM
PROTIUM I.V.
Protonix
Protonix i.v.
Protonix IV
SK And F 96022
SK And F96022
SK And F-96022
SK&F-96022
SK-96022
SKF-96022
|
|
11 |
|
Famotidine |
Approved |
Phase 4 |
|
76824-35-6 |
3325 5702160 |
Synonyms:
(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide
(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulphamide
3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide
3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulphonyl)propanimidamide
3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine
3-{[(2-CARBAMIMIDAMIDO-1,3-THIAZOL-4-YL)METHYL]SULFANYL}-N-SULFAMOYLPROPANIMIDAMIDE
Amfamox
Antodine
Apo-famotidine
Apogastine
Bestidine
Blocacid
Brolin
Cepal
Confobos
Cronol
Cuantin
Famocid
Famodar
Famodil
Famodin
Famodine
Famogard
Famonit
Famopsin
Famos
Famosan
Famotal
Famotep
Famotidina
Famotidine
Famotidine hydrochloride
FAMOTIDINE PRESERVATIVE FREE
Famotidinum
Famotin
Famovane
Famowal
Fluxid
GASTER
Gaster®|MK-208|Pepcid®
Gastridan
Gastridin
Gastrion
Gastro
Gastrodomina
Gastrofam
Gastropen
Gastrosidin
Hacip
Huberdina
Ingastri
Invigan
|
L 643341
Lecedil
Logos
Mensoma
Midefam
MK-208
Mosul
Motiax
Muclox
Mylanta ar
Neocidine
Nevofam
Notidin
Novo-famotidine
N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide
N-Sulphamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide
Nulceran
Nulcerin
Panalba
Pepcid
PEPCID AC
PEPCID PRESERVATIVE FREE
PEPCID RPD
Pepcidin
Pepcidin pepcidine
PEPCIDIN PEPCIDINE
Pepdine
Pepdul
Pepfamin
Peptan
Peptidin
Purifam
Quamatel
Quamtel
Renapepsa
Restadin
Rogasti
Rubacina
Tamin
Tipodex
Topcid
Ulcatif
Ulceprax
Ulcofam
Ulfagel
Ulfam
Ulfamid
Ulfinol
Ulgarine
Vagostal
YM-11170
|
|
12 |
|
Histamine |
Approved, Investigational |
Phase 4 |
|
51-45-6 |
774 |
Synonyms:
1H-Imidazole-4-ethanamine
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(3H-Imidazol-4-yl)ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-Imidazolyl)ethylamine
2-Imidazol-4-ylethylamine
2-Imidazol-4-yl-ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-Imidazoleethylamine
5-Imidazoleethylamine
|
beta-Aminoethylglyoxaline
beta-Aminoethylimidazole
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
b-Imidazolyl-4-ethylamine
Eramin
Ergamine
Ergotidine
Histamine
HSM
Imidazole-4-ethylamine
NSC-33792
Î’-imidazolyl-4-ethylamine
|
|
13 |
|
Citric acid |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
77-92-9 |
311 |
Synonyms:
2-hydroxy-1,2,3-propanetricarboxyic acid
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylate
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Acid monohydrate, citric
ácido cítrico
Acidum citricum
Aciletten
Anhydrous citrate
Anhydrous citric acid
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
Chemfill
Citraclean
Citrate
Citrate anhydrous
Citretten
CITRIC ACID
Citric acid anhydrous
CITRIC ACID HYDRATE
Citric acid monoglyceride
|
Citric acid monohydrate
Citric acid, anhydrous
Citric acid,anhydrous
Citro
Citronensaeure
Citronensäure
e 330
e330
E-330
FEMA NO. 2306
H3Cit
Hydrocerol a
INS NO.330
INS-330
Kyselina citronova
Monohydrate, citric acid
NSC-112226
NSC-30279
NSC-626579
Suby g
Uralyt u
UROLOGIC G
Uro-trainer
|
|
14 |
|
Furazolidone |
Experimental, Vet_approved |
Phase 4 |
|
67-45-8 |
5323714 |
Synonyms:
3-(((5-Nitro-2-furanyl)methylene)amino)-2-oxazolidinone
3-((5-Nitrofurfurylidene)amino)-2-oxazolidinone
3-((5-Nitrofurfurylidene)amino)-2-oxazolidone
3-((5-Nitrofurfurylidine)amino)-2-oxazolidinone
3-((5-Nitrofurylidene)amino)-2-oxazolidone
3-(5'-Nitrofurfuralamino)-2-oxazolidone
3-(5-Nitrofurfurylideneamino)-2-oxazolidinone
3-[(5-Nitrofurfurylidene)amino]-2-oxazolidinone
3-[(5-Nitrofurfurylidene)amino]-2-oxazolidone
3-[(5-Nitrofurfurylidine)amino]-2-oxazolidinone
3-[(5-Nitrofurylidene)amino]-2-oxazolidone
3-[(e)-(5-Nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one
3-[[(5-Nitro-2-furanyl)methylene]amino]-2-oxazolidinone
3-[[(5-Nitro-2-furanyl)methylene]-amino]-2-oxazolidinone
3-[[(5-Nitro-2-furanyl)methylene]amino]-2-oxazolidinone, 9ci
3-{[(5-nitro-2-furanyl)methylene]amino}-2-oxazolidinone
5-Nitro-N-(2-oxo-3-oxazolidinyl)-2-furanmethanimine
Bifuron
Corizium
Coryzium
Diafuron
Enterotoxon
Fiurox aerosol powder
Furall
Furaxon
Furaxone
Furazol
Furazolidine
Furazolidona
Furazolidone
Furazolidonum
Furazon
Furidon
Furovag
Furox
|
Furoxal
Furoxane
Furoxon
Furoxone
Furoxone swine mix
Furozolidine
FZL
Giardil
Giarlam
Medaron
N-(5-Nitro-2-furfurylidene)-3-amino-2-oxazolidone
N-(5-Nitro-2-furfurylidene)-3-aminooxazolidine-2-one
Neftin
Nicolen
Nifulidone
Nifuran
Nifurazolidone
Nitrofurazolidone
Nitrofurazolidonum
Nitrofuroxon
NSC-6469
Optazol
Ortazol
Puradin
Roptazol
Sclaventerol
Tikofuran
Topazone
Trichofuron
Tricofuron
Tricoron
Trifurox
USAF ea-1
Viofuragyn
|
|
15 |
|
Bismuth tripotassium dicitrate |
|
Phase 4 |
|
|
|
16 |
|
Bismuth |
|
Phase 4 |
|
7440-69-9 |
105143 |
Synonyms:
Bi
Bi(3+)
Bismuth(III) cation
|
Bismuth-209
Bisumth(3+) ion
|
|
17 |
|
Citrate |
|
Phase 4 |
|
|
|
18 |
|
Antibiotics, Antitubercular |
|
Phase 4 |
|
|
|
19 |
|
Anti-Bacterial Agents |
|
Phase 4 |
|
|
|
20 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
21 |
|
Antiprotozoal Agents |
|
Phase 4 |
|
|
|
22 |
|
Antiparasitic Agents |
|
Phase 4 |
|
|
|
23 |
|
Expectorants |
|
Phase 4 |
|
|
|
24 |
|
Antimalarials |
|
Phase 4 |
|
|
|
25 |
|
Respiratory System Agents |
|
Phase 4 |
|
|
|
26 |
|
Anti-Infective Agents, Local |
|
Phase 4 |
|
|
|
27 |
|
Monoamine Oxidase Inhibitors |
|
Phase 4 |
|
|
|
28 |
|
diuretics |
|
Phase 4 |
|
|
|
29 |
|
Ranitidine bismuth citrate |
|
Phase 4 |
|
|
|
Synonyms:
GR-122311X
PYLORID
RANITIDINE BISMUTH CITRATE
|
RANITIDINE BISMUTREX
TRITEC
|
|
30 |
|
Anti-Ulcer Agents |
|
Phase 4 |
|
|
|
31 |
|
Antacids |
|
Phase 4 |
|
|
|
32 |
|
Proton Pump Inhibitors |
|
Phase 4 |
|
|
|
33 |
|
Gastrointestinal Agents |
|
Phase 4 |
|
|
|
34 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
35 |
|
Histamine phosphate |
|
Phase 4 |
|
51-74-1 |
134614 |
Synonyms:
2)
4-(2-AMINOETHYL)IMIDAZOLE BIS(DIHYDROGEN PHOSPHATE)
4-(2-AMINOETHYL)IMIDAZOLE DI-ACID PHOSPHATE
HISTAMINE ACID PHOSPHATE
|
HISTAMINE BIPHOSPHATE
HISTAMINE DIHYDROGEN PHOSPHATE
HISTAMINE DIPHOSPHATE
HISTAMINE PHOSPHATE (1
|
|
36 |
|
Histamine H2 Antagonists |
|
Phase 4 |
|
|
|
37 |
|
Histamine Antagonists |
|
Phase 4 |
|
|
|
38 |
|
Clarithromycin |
Approved |
Phase 3 |
|
81103-11-9 |
84029 |
Synonyms:
6-O-METHYL ERYTHROMYCIN
6-O-Methylerythromycin
6-O-Methylerythromycin a
A-56268
ABBOTT-56268
Biaxin
BIAXIN XL
BIAXIN XL PAC
CAM
CLA
CLARIE XL
CLARITHROMYCIN
CLARITHROMYCIN EXTENDED RELEASE
CLARITHROMYCIN IDENTITY
Clarithromycina
Clarithromycine
|
Clarithromycinum
Claritromicina
CLAROSIP
Clathromycin
FEBZIN XL
KLARICID
KLARICID 500
KLARICID ADULT
KLARICID I.V.
KLARICID PAED
KLARICID XL
MYCIFOR XL
PREVPAC
TE-031
XETININ XL
ZECLAR
|
|
39 |
|
Metronidazole |
Approved |
Phase 2, Phase 3 |
|
443-48-1, 69198-10-3 |
4173 |
Synonyms:
1-(2-Hydroxy-1-ethyl)-2-methyl-5-nitroimidazole
1-(2-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(beta-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Oxyethyl)-2-methyl-5-nitroimidazole
1-(b-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(b-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(b-Oxyethyl)-2-methyl-5-nitroimidazole
1-(Î’-ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(Î’-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(Î’-oxyethyl)-2-methyl-5-nitroimidazole
2 Methyl 5 nitroimidazole 1 ethanol
2-Methyl-1-(2-hydroxyethyl)-5-nitroimidazole
2-Methyl-3-(2-hydroxyethyl)-4-nitroimidazole
2-Methyl-5-nitroimidazole-1-ethanol
ACEA
Acromona
ANABACT
Anagiardil
Apo-Metronidazole
Arilin
Atrivyl
BAY-5360
Bayer 5360
BAYER-5360
Bexon
Clont
Cont
Danizol
Deflamon
Deflamon-Wirkstoff
DRAZIFON
Efloran
ELYZOL
Entizol
Eumin
Flagemona
Flagesol
Flagil
Flagyl
FLAGYL 375
FLAGYL COMPAK
FLAGYL ER
Flagyl I.V.
FLAGYL I.V. RTU IN PLASTIC CONTAINER
FLAGYL-400
FLAGYL-S
Flegyl
Fossyol
Giatricol
Gineflavir
Hydrochloride, metronidazole
Klion
Klont
Meronidal
Methronidazole
Metric
METRIC 21
Metro Cream
Metro I.V.
Metro I.V. In Plastic Container
METRO IV
METROCREAM
Metrodzhil
MetroGel
Metrogel-vaginal
Metrogyl
Metrolag
METROLOTION
METROLYL
|
METROMIDOL
Metronidaz
Metronidazol
METRONIDAZOLE
Métronidazole
Metronidazole benzoate
Metronidazole Hcl
Metronidazole hydrochloride
Metronidazole in plastic container
Metronidazole monohydrochloride
Metronidazole phosphate
Metronidazole phosphoester
Metronidazolo
Metronidazolum
METROSA
METROTOP
Mexibol
Monagyl
Monasin
Monohydrochloride, metronidazole
Nalox
Neo-Tric
NEUTRATOP
Nida
Nidagel
Noritate
Noritic acid
NORZOL
Novonidazol
NSC-50364
NSC-69587
NUVESSA
Orvagil
Phosphate, metronidazole
Phosphoester, metronidazole
PROTOSTAT
Rathimed
ROSICED
ROZEX
RP-8823
Sanatrichom
Satric
Takimetol
Trichazol
Trichex
Tricho Cordes
Trichocide
Tricho-Gynaedron
Trichomol
Trichopal
Trichopol
Tricocet
Tricom
Tricowas B
Trikacide
Trikamon
Trikojol
Trikozol
Trimeks
Trivazol
Vagilen
Vagimid
VAGINYL
VANDAZOLE
Vertisal
Wagitran
ZADSTAT
ZIDOVAL
ZYOMET
|
|
40 |
|
Rabeprazole |
Approved, Investigational |
Phase 2, Phase 3 |
|
117976-89-3, 117976-90-6 |
5029 |
Synonyms:
1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, sodium salt
2-((4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1H-benzimidazole
Aciphex
ACIPHEX SPRINKLE
Clofezone
Dexrabeprazole
E3810
E-3810
E-3810 (PPI)
E-3810 SODIUM
Eraloc
Habeprazole
Irsogladine Maleate
|
LY307640
LY-307640
LY307640 SODIUM
LY-307640 SODIUM
Pariet
Pariets
RABEPRAZOLE
Rabeprazole sodium
RABEPRAZOLE SODIUM SALT
Rebeprazole sodium
Sodium rabeprazole
Sodium, rabeprazole
|
|
41 |
|
Rebamipide |
Approved, Investigational |
Phase 2, Phase 3 |
|
90098-04-7 |
5042 |
Synonyms:
2-(4-CHLOROBENZOYLAMINO)-3-(1,2-DIHYDRO-2-OXO-4-QUINOLYL)PROPIONIC ACID
2-(4-chlorobenzoylamino)-3-(2(1H)-Quinolinon-4-yl)propionic acid
2-[(4-Chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoate
Mucosta
OPC-12759
OPC-12759|pramipide
OPC759
|
PRAMIPIDE
Rebamipida
Rebamipide
Rébamipide
Rebamipide, (-)-isomer
Rebamipide, (+)-isomer
Rebamipidum
|
|
42 |
|
Cimetidine |
Approved, Investigational |
Phase 3 |
|
51481-61-9 |
2756 |
Synonyms:
1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine
2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine
ACID-EZE
ACITAK 200
ACITAK 400
ACITAK 800
Altramet
Biomet
Biomet400
BRUMETADINA
Cimetag
CIMETIDIN
Cimetidina
CIMETIDINE
CIMÉTIDINE
Cimetidine HCL
cimetidine HCl|Tagamet®
Cimetidine hydrochloride
Cimetidinum
DYSPAMET
Eureceptor
GALENAMET
HCL, Cimetidine
Histodil
|
Hydrochloride, cimetidine
KENTAMET
N-Cyano-n'-methyl-n''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine
N-Cyano-n'-methyl-n''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine
N-Cyano-n'-methyl-n''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulphanyl)ethyl)guanidine
N''-cyano-N-methyl-n'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine
NSC-335308
PEPTIMAX 200
PEPTIMAX 400
PEPTIMAX 800
SK And F 92334
SK And F92334
SK And F-92334
SKF-92334
TAGADINE
Tagamet
TAGAMET 100
TAGAMET HB
Tagamet HB 200
Ulcerfen
ULTEC
VALMAGEN
ZITA
|
|
43 |
|
Ketoprofen |
Approved, Vet_approved |
Phase 3 |
|
22071-15-4 |
3825 |
Synonyms:
19583RP
2-(3-Benzoylphenyl)propionate
2-(3-Benzoylphenyl)propionic acid
3-Benzoyl-alpha-methylbenzeneacetate
3-Benzoyl-alpha-methylbenzeneacetic acid
3-Benzoyl-a-methylbenzeneacetate
3-Benzoyl-a-methylbenzeneacetic acid
3-Benzoylhydratropate
3-Benzoylhydratropic acid
3-Benzoyl-α-methylbenzeneacetate
3-Benzoyl-α-methylbenzeneacetic acid
ACTRON
Actron®|Orudis®
Alrheumat
Alrheumum
Alrheumun
AXORID
Benzoylhydratropic acid
Capisten
Dexal
Epatec
Fastum
FENOKET 200
IDEA-033
Iso-K
JOMETHID XL
Kefenid
KETOCID 200
KETONAL
KETOPROFEN
Ketoprofeno
Ketopron
KETOTARD 200 XL
|
KETOVAIL
KETOZIP 200 XL
L'acide (benzoyl-3-phenyl)-2-propionique
LARAFEN
LARAFEN CR
Lertus
m-Benzoylhydratropate
m-Benzoylhydratropic acid
Menamin
Meprofen
NEXCEDE
Orudis
ORUDIS (TN)
ORUDIS 100
ORUDIS KT
Orugesic
ORUVAIL
ORUVAIL 100
ORUVAIL 150
ORUVAIL 200
ORUVAIL IM
Oscorel
POWERGEL
Profenid
R.P. 19583
RP-19583
RU-4733
TILOKET
TILOKET CR
Toprec
Toprek
VALKET 200 RETARD
|
|
44 |
|
Acetylsalicylic acid |
Approved, Vet_approved |
Phase 3 |
|
50-78-2 |
2244 |
Synonyms:
2-(ACETYLOXY)BENZOATE
2-(ACETYLOXY)benzoIC ACID
2-Acetoxybenzenecarboxylate
2-ACETOXYBENZENECARBOXYLIC ACID
2-ACETOXYBENZOATE
2-ACETOXYBENZOIC ACID
2-CARBOXYPHENYL ACETATE
8-HOUR BAYER
A.S.A.
A.S.A. Empirin
ACARD
ACENTERINE
Acesal
Acetal
ACETARD
ACETICYL
Acetilsalicilico
Acetilum acidulatum
Acetisal
ACETOL
ACETONYL
ACETOPHEN
Acetophen®|acetylsalicylic acid|Aspirin®
ACETOSAL
ACETOSALIC ACID
ACETOSALIN
Acetoxybenzoic acid
ACETYLIN
Acetylsal
ACETYLSALIC ACID
ACETYLSALICYLATE
ACETYLSALICYLIC ACID
Acetylsalicylsaeure
Acetylsalicylsaure
ACETYLSALICYLSÄURE
ACETYONYL
ACETYSAL
ACETYSALICYLIC ACID
Acid, acetylsalicylic
Acide 2-(acetyloxy)benzoique
ACIDE 2-(ACÉTYLOXY)BENZOÏQUE
Acide acetylsalicylique
ACIDE ACÉTYLSALICYLIQUE
Acido acetilsalicilico
ÁCIDO ACETILSALICÍLICO
Acido O-acetil-benzoico
ACIDUM ACETYLSALICYLICUM
Acimetten
Acisal
ACYLPYRIN
Adiro
ALKA RAPID
Aloxiprimum
ANADIN ALL NIGHT
ANGETTES 75
ASA
Asagran
ASATARD
Ascoden-30
Aspalon
Aspec
ASPERGUM
ASPIRDROPS
ASPIRIN
Aspirina
Aspirine
Aspro
ASPRO CLR
Asteric
Azetylsalizylsaeure
AZETYLSALIZYLSÄURE
BAY1019036
BAYER EXTRA STRENGTH
Bayer Extra Strength Aspirin For Migraine Pain
BENASPIR
Bialpirina
BIALPIRINIA
Bi-prin
BUFFERIN
CAPRIN
CARDIOASPIRINA
Cemirit
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Crystar
DANAMEP
Decaten
Delgesic
Dispril
DISPRIN CV
|
DISPRIN DIRECT
Dolean pH 8
Duramax
DURLAZA
EASPRIN
ECM
ECOLEN
ECOTRIN
EMPIRIN
ENDOSPRIN
ENDYDOL
ENPRIN
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
EQUI-PRIN
Extren
GENCARDIA
Globentyl
Globoid
Helicon
Idragin
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LEVIUS
Magnecyl
MAX STRGH ASPRO CLR
MEASURIN
Micristin
MICROPIRIN EC
Neuronika
Novid
NSC-27223
NSC-406186
Nu-seals
NU-SEALS 300
NU-SEALS 600
NU-SEALS 75
Nu-seals aspirin
NU-SEALS CARDIO 75
O-(ACETYLOXY)BENZOATE
O-(ACETYLOXY)BENZOIC ACID
O-accetylsalicylic acid
O-ACETOXYBENZOATE
O-ACETOXYBENZOIC ACID
O-Acetylsalicylate
O-ACETYLSALICYLIC ACID
O-CARBOXYPHENYL ACETATE
O-Carboxyphenyl acetic acid
PAYNOCIL
PERSISTIN
PHARMACIN
Pirseal
PLATET
PLATET 300
Polopirin
POLOPIRYNA
POSTMI 300
POSTMI 75
PREMASPIN
RHEUMINTABLETTEN
RHODINE
Rhonal
Salacetin
SALCETOGEN
SALETIN
Salicylate acetate
SALICYLIC ACID ACETATE
Salicylic acid acetic acid
Salicylic acid, acetate
SALOSPIR
Solfrin
SOLPRIN
SOLPRIN ACID
SOLPYRON
Solupsan
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
Supac
TASPRIN
TEMPERAL
TOLDEX
TRIAMINICIN
Triple-sal
Vanquish
VAZALORE
Xaxa
Yasta
Zorprin
|
|
45 |
|
Gefarnate |
Investigational |
Phase 3 |
|
51-77-4 |
3459 |
Synonyms:
|
46 |
|
Cytochrome P-450 CYP3A Inhibitors |
|
Phase 3 |
|
|
|
47 |
|
Analgesics |
|
Phase 3 |
|
|
|
48 |
|
Cytochrome P-450 Enzyme Inhibitors |
|
Phase 3 |
|
|
|
49 |
|
Antirheumatic Agents |
|
Phase 3 |
|
|
|
50 |
|
Cyclooxygenase Inhibitors |
|
Phase 3 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 82)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Evaluation of the Efficacy of Concomitant Therapy for Eradication of Helicobacter Pylori |
Unknown status |
NCT01922765 |
Phase 4 |
amoxicillin, clarithromycin, metronidazole, rabeprazole |
2 |
The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers: A Randomized, Parallel-controlled Multi-center Study |
Completed |
NCT03342456 |
Phase 4 |
Doxycycline Hyclate Enteric-Coated Capsules;Amoxicillin Capsules;Ilaprazole Enteric-Coated Tablets;Furazolidone Tablets;Potassium Citrate Tablets |
3 |
Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori Infection - A Combination of Clinical and Pharmacogenetic Study |
Completed |
NCT00854451 |
Phase 4 |
omeprazole plus amoxicillin |
4 |
Comparison of Esomeprazole and Famotidine for Stress Ulcer Prophylaxis in Neurosurgical Intensive Care Unit |
Completed |
NCT00633035 |
Phase 4 |
esomeprazole 40 mg;famotidine 20 mg |
5 |
Sup-Icu RENal (SIREN) - a Sub-analysis of the Prospective SUP (Stress Ulcer Prophylaxis)-ICU Trial on the Risk of GI- Bleeding in ICU Patients Receiving Renal Replacement Therapy |
Completed |
NCT02718261 |
Phase 4 |
Pantoprazole;Saline 0.9% (matching placebo) |
6 |
Phase IV Study of Comparison of the Efficacy for Stress Ulcer Prophylaxis Between the Patients Received Lansoprazole OD and Control Group Weaning From Mechanical Ventilator in Respiratory Care Center: a Randomized Control Trial |
Completed |
NCT00708149 |
Phase 4 |
lansoprazole OD;placebo |
7 |
A Clinico-Bacteriological Study and Effect of Stress Ulcer Prophylaxis on Occurrence of Ventilator Associated Pneumonia: a Randomized Prospective Study |
Completed |
NCT00702871 |
Phase 4 |
Ranitidine;Sucralfate |
8 |
Stress Ulcer Prophylaxis in the Intensive Care Unit (SUP-ICU) |
Completed |
NCT02467621 |
Phase 4 |
Pantoprazole |
9 |
Effect of Prevacid on Prostaglandin Levels in the Gastric Mucosa of Patients With Stress Ulcer |
Completed |
NCT00239551 |
Phase 4 |
Prevacid |
10 |
Stress Ulcer Prophylaxis Versus Placebo - a Blinded Randomized Control Trial to Evaluate the Safety of Two Strategies in Critically Ill Infants With Congenital Heart Disease |
Completed |
NCT03667703 |
Phase 4 |
Famotidine;Placebo |
11 |
Effect of Intravenous Esomeprazole Versus Ranitidine on Gastric pH in Critically Ill Patients - a Prospective, Randomized, Double-Blind Study. |
Completed |
NCT00590928 |
Phase 4 |
esomeprazole;ranitidine |
12 |
Comparison of Intravenous Pantoprazole and Famotidine for Stress Ulcer Prophylaxis in Patients After Major Abdominal Surgery |
Terminated |
NCT00839488 |
Phase 4 |
pantoprazole 40 mg iv;famotidine 20 mg iv |
13 |
A Phase 3,Double-blinded, Double Dummy, Positive Drug, Parallel, Randomised Controlled Multicenter Trial to Evaluate Efficacy and Safety of Anaprazole Compared With Rabeprazole in Patients With Duodenal Ulcers. |
Unknown status |
NCT04215653 |
Phase 3 |
Anaprazole Sodium;Rabeprazole;Rabeprazole Placebo;Anaprazole Sodium Placebo |
14 |
Pharmacogenomics-Based Tailor-Made Strategy for Eradication of Helicobacter Pylori |
Unknown status |
NCT00149084 |
Phase 3 |
Lansoprazole, clarithromycin, amoxicillin |
15 |
Dual Therapy With High-Dose of Rabeprazole and Amoxicilline Versus Triple Therapy With Rabeprazole, Amoxicilline and Metronidazole as the Second Line Therapy for the Cure of H. Pylori Infection |
Unknown status |
NCT00197418 |
Phase 2, Phase 3 |
rabeprazole, amoxicillin, clarithromycin, metronidazole |
16 |
A Randomized Double-Blind, Double-Dummy, Phase 3 Study to Evaluate the Efficacy and Safety of Oral TAK-438 20 mg Compared to Lansoprazole 30 mg Once- or Twice-Daily in the Treatment of Endoscopically Confirmed Duodenal Ulcer Subjects With or Without Helicobacter Pylori Infection |
Completed |
NCT03050359 |
Phase 3 |
TAK-438;Lansoprazole;TAK-438 Placebo;Lansoprazole Placebo;Bismuth-Containing Quadruple Therapy |
17 |
Efficacy and Safety of Ilaprazole for Acute Duodenal Ulcer: A Randomized,Double-Blind,Omeprazole-Controlled,Multicenter,and Phase3 Trial in China |
Completed |
NCT00952978 |
Phase 3 |
10 mg ilaprazole;20 mg omeprazole |
18 |
A Phase 3, Randomized, Double Blind, Double-Dummy, Multicenter, Parallel Group Comparison Study to on Efficacy and Safety of Oral Once-Daily Administration of TAK-438 20 mg Comparing With AG-1749 in Patients With Duodenal Ulcer |
Completed |
NCT01452724 |
Phase 3 |
TAK-438;Placebo;Lansoprazole |
19 |
Efficacy and Safety of Ilaprazole for Acute Duodenal Ulcer: A Randomized,Double-Blind,Rabeprazole-Controlled,Multicenterand Phase3 Trial in China in China |
Completed |
NCT02847455 |
Phase 2, Phase 3 |
5 mg ilaprazole;10 mg ilaprazole;10 mg Rabeprazole |
20 |
A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy |
Completed |
NCT01568398 |
Phase 3 |
TAK-438 |
21 |
A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy |
Completed |
NCT01568385 |
Phase 3 |
TAK-438 |
22 |
A Study to Investigate the Preventive Effect of AG-1749 Against the Recurrence of Gastric and Duodenal Ulcers During Long-term Treatment With Nonsteroid Anti-inflammatory Drug |
Completed |
NCT00787254 |
Phase 3 |
Lansoprazole;Gefarnate |
23 |
A Phase III, Multicentre, Randomised, Double-blind, Parallel-group, Comparative Efficacy and Safety Study of Esomeprazole(20 mg Once Daily) Versus Placebo for the Prevention of Gastric and/or Duodenal Ulcers Associated With Daily Nonsteroidal Anti-inflammatory Drug (NSAID) Use |
Completed |
NCT00542789 |
Phase 3 |
Esomeprazole;Placebo |
24 |
A Randomized, Double-blind, Parallel-group, Multicentre, Phase III Study to Assess the Effect of Esomeprazole 20 or 40 mg od Versus Placebo on the Occurrence of Peptic Ulcers During 26 Weeks in Subjects on Continuous Low Dose Acetylsalicylic Acid (ASA) |
Completed |
NCT00441727 |
Phase 3 |
Esomeprazole 40 mg;Esomeprazole 20 mg;Placebo |
25 |
High Eradication Rates of Helicobacter Pylori With a New Sequential Treatment |
Completed |
NCT00132171 |
Phase 3 |
Sequential therapy |
26 |
A Long Term Study to Investigate the Efficacy and Safety Study of D961H (Esomeprazole) (20 mg Once Daily) for the Prevention of Gastric and/or Duodenal Ulcers Associated With Daily Nonsteroidal Anti-inflammatory Drug (NSAID) Use |
Completed |
NCT00595517 |
Phase 3 |
Esomeprazole 20 mg |
27 |
An Open-label, Parallel-group, Multi-centre, Phase I/III Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Repeated Once-daily Oral Administration of D961H 10 mg and D961H 20 mg in Japanese Paediatric Patients 1 to 14 Years Old With Gastrointestinal Acid Related Diseases |
Completed |
NCT02153398 |
Phase 3 |
D961H sachet 10 mg;D961H capsule 10mg;D961H capsule 20 mg |
28 |
Cytoprotective Agent for Peptic Ulcer Prevention in Patients Taking Dual Antiplatelet Agents: A Randomized Double-blind Placebo Control Trial Study |
Completed |
NCT02166008 |
Phase 2, Phase 3 |
Repamipide;Placebo |
29 |
A Phase III Multinational, Multicenter, Randomized, Double-blind, Parallel-group, Comparative Efficacy and Safety Study of D961H (20 mg Once Daily) Versus Placebo for Prevention of Gastric and/or Duodenal Ulcers Associated With Continuous Low-dose Aspirin (LDA) Use |
Completed |
NCT01069939 |
Phase 3 |
Esomeprazole;Placebo |
30 |
A Phase 3, Multicenter, Randomized, Double-blind, AG-1749-controlled, Parallel-group, Comparison Study to Evaluate the Efficacy and Safety of TAK-438 (10 mg or 20 mg, Orally, Once Daily) for the Prevention of Recurrent Gastric or Duodenal Ulcers During Long-term Therapy of Low-dose Aspirin |
Completed |
NCT01452763 |
Phase 3 |
TAK-438;Placebo;Lansoprazole |
31 |
A Phase 3, Multicenter, Randomized, Double-blind, AG-1749-controlled, Parallel-group, Comparison Study to Evaluate the Efficacy and Safety of TAK-438 (10 mg or 20 mg, Orally, Once Daily) for the Prevention of Recurrent Gastric or Duodenal Ulcers During Long-term Therapy of Non-steroidal Anti-inflammatory Drug (NSAID). |
Completed |
NCT01452750 |
Phase 3 |
TAK-438;Placebo;Lansoprazole |
32 |
A Phase 3, Multicenter, Single-blind, AG-1749-controlled, Parallel-group, Long-term Extension Study to Evaluate the Safety and Efficacy of TAK-438 (10 mg or 20 mg, Orally, Once Daily) for the Prevention of Recurrent Gastric or Duodenal Ulcers During Long-term Therapy of Non-steroidal Anti-inflammatory Drug (NSAID) |
Completed |
NCT01456260 |
Phase 3 |
TAK-438;Placebo;Lansoprazole |
33 |
A Phase 3, Multicenter, Single-blind, AG-1749-controlled, Parallel-group, Long-term Extension Study to Evaluate the Safety and Efficacy of TAK-438 (10 mg or 20 mg, Orally, Once Daily) for the Prevention of Recurrent Gastric or Duodenal Ulcers During Long-term Therapy of Low-dose Aspirin |
Completed |
NCT01456247 |
Phase 3 |
TAK-438;Placebo;Lansoprazole |
34 |
Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment. - A Multicenter, Randomized, Parallel-group, Open-label Trial- |
Completed |
NCT01398410 |
Phase 2, Phase 3 |
Rabeprazole |
35 |
Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment. - A Multicenter, Randomized, Parallel-group, Double-blind Comparative Trial- |
Completed |
NCT01397448 |
Phase 2, Phase 3 |
E3810;Teprenone |
36 |
Effect of Intravenous Esomeprazole Versus Cimetidine in Prevention of Stress Ulcer Prophylaxis in Chinese Seriously Ill Patients - a Randomized, Double-blind, Parallel-group Study |
Completed |
NCT02157376 |
Phase 3 |
Esomeprazole;Cimetidine |
37 |
Re-Evaluating the Inhibition of Stress Erosions: Gastrointestinal Bleeding Prophylaxis In ICU |
Completed |
NCT02290327 |
Phase 3 |
Pantoprazole;Placebo |
38 |
A Comparative Efficacy and Safety of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Placebo for the Prevention of Gastric and Duodenal Ulcers Associated With Daily NSAID Use in Patients at Risk |
Completed |
NCT00629928 |
Phase 3 |
Esomeprazole;Placebo |
39 |
Safety, Tolerability and Efficacy of FDC Ketoprofen + Omeprazole in Patients With Rheumatological Conditions With History or Who Are at Risk of Developing NSAID Associated Benign Gastric Ulcers, Duodenal Ulcers and Gastroduodenal Erosions |
Completed |
NCT00971581 |
Phase 3 |
FDC KETOPROFEN+OMEPRAZOLE |
40 |
A Multi-center, Randomized, Double-blind, Active-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of LXI-15028 Compared to Lansoprazole in the Treatment of Duodenal Ulcer in Chinese Patients for up to 6 Weeks |
Recruiting |
NCT05010954 |
Phase 3 |
LXI-15028 50mg group;Lansoprazole 30mg group |
41 |
An Open Label, Parallel Group, Multi-centre, Phase III Study to Assess the Efficacy and Safety of D961H for the Maintenance Therapy Following Initial Treatment in Japanese Paediatric Patients With Reflux Esophagitis and for the Prevention of Recurrence of Gastric Ulcer or Duodenal Ulcer in Japanese Paediatric Patients Treated With Non-steroidal Anti-inflammatory Drugs or Low-dose Aspirin |
Active, not recruiting |
NCT03553563 |
Phase 3 |
D961H capsule 10mg;D961H sachet 10mg |
42 |
A Study to Investigate the Preventive Effect of AG-1749 Against the Recurrence of Gastric And Duodenal Ulcers During Long-Term Treatment With Low Dose Aspirin. |
Terminated |
NCT00762359 |
Phase 3 |
Lansoprazole;Gefarnate |
43 |
Efficacy and Safety of Ilaprazole for Acute Duodenal Ulcer: A Randomized,Double-Blind,Omeprazole-Controlled,Multicenter,and Phase2 Trial in China |
Completed |
NCT00953381 |
Phase 2 |
5 mg ilaprazole;10 mg ilaprazole;20 mg ilaprazole;20 mg omeprazole |
44 |
MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001) |
Completed |
NCT00543868 |
Phase 2 |
MK0782 |
45 |
A Phase 2,Double-blinded, Double Dummy, Positive Drug, Parallel, Randomised Controlled Multicenter Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers. |
Completed |
NCT04503629 |
Phase 2 |
Anaprazole Sodium;Rabeprazole sodium |
46 |
An Open Label, Randomised, Single Center, 2 Way Crossover Study to Assess Bioequivalence Between a Commercial HPMC Capsule of D961H 20 mg and a Pellets Based Sachet Formulation of D961H 20 mg by Pharmacodynamics (Intragastric pH) After Once-daily Repeated Oral Administration in Japanese Healthy Male Subjects |
Completed |
NCT01964131 |
Phase 1 |
D961H sachet 20 mg;D961H HPMC capsule 20 mg |
47 |
Pharmacodynamic Dose-Response of S-Tenatoprazole-Na (STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers |
Completed |
NCT00284908 |
Phase 1 |
S-Tenatoprazole-Na (STU-Na) |
48 |
An Open Label, Balanced, Randomized, Three-treatment, Three-period, Six-sequence, Cross-over, Single Dose, Comparative Bioavailability Pilot Study of Two Test Formulations of Fixed Dose Combination Capsules of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Manufactured by Piramal Healthcare Limited, India for GSK Comparing With Aspirin® Protect 100 mg Tablets by Bayer Vital GmbH, and Protium® 20 mg Gastro-resistant Tablets by Nycomed GmbH, in Healthy, Adult, Human Subjects, Under Fasting Conditions |
Completed |
NCT01847404 |
Phase 1 |
Test 1= ASA 100 mg and pantoprazole 20 mg capsule formulation one;Test 2= ASA 100 mg and pantoprazole 20 mg capsule formulation two;ASA 100 mg tablet;Pantoprazole 20 mg gastro-resistant tablet |
49 |
An Open Label, Balanced, Randomized, Three-treatment, Three-period, Six-sequence, Cross-over, Single Dose, Comparative Bioavailability Pilot Study of Two Test Formulations of Fixed Dose Combination Capsules of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Manufactured by Piramal Healthcare Limited, India for GSK Comparing With Aspirin® Protect 100 mg Tablets by Bayer Vital GmbH, and Protium® 20 mg Gastro-resistant Tablets by Nycomed GmbH, in Healthy, Adult, Human Subjects, Under Fed Conditions |
Completed |
NCT01847417 |
Phase 1 |
Test 1= ASA 100 mg and pantoprazole 20 mg capsule formulation one;Test 2= ASA 100 mg and pantoprazole 20 mg capsule formulation two;ASA 100 mg tablet;Pantoprazole 20 mg gastro-resistant tablet |
50 |
Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer Bleeding |
Unknown status |
NCT02108756 |
|
L-pantoprazole sodium;Panmeilu |
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Aluminum carbonate
Aluminum Hydroxide
Aluminum Hydroxide / Magnesium Hydroxide
Aluminum Hydroxide Gel
aluminum hydroxide, dried (USP)
basic aluminum carbonate gel
Calcium Carbonate
CALCIUM CARBONATE 1 g in 1 g ORAL POWDER
Calcium gluceptate
Cimetidine
Cimetidine Hydrochloride
dihydroxyaluminum sodium carbonate
Esomeprazole
Esomeprazole magnesium
esomeprazole sodium
|
Esomeprazole Strontium
Famotidine
lansoprazole
magaldrate
Magnesium Hydroxide
Maprotiline
Maprotiline Hydrochloride
MILK OF MAGNESIA
Nizatidine
Omeprazole
Omeprazole 2 MG/ML Oral Suspension
Omeprazole magnesium
Prazepam
rabeprazole
Sucralfate
|
Cochrane evidence based reviews: duodenal ulcer
|